Holen Sie sich die Stockscreener-App
259.79
7.02%
-19.62
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$279.41
Offen:
$279.26
24-Stunden-Volumen:
1.50M
Relative Volume:
2.11
Marktkapitalisierung:
$18.69B
Einnahmen:
$2.96B
Nettoeinkommen (Verlust:
$487.70M
KGV:
38.92
EPS:
6.6758
Netto-Cashflow:
$344.00M
1W Leistung:
-5.71%
1M Leistung:
-2.50%
6M Leistung:
+15.78%
1J Leistung:
-22.96%
1-Tages-Spanne:
$259.39
$279.39
1-Wochen-Bereich:
$259.39
$281.55
52-Wochen-Spanne:
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
259.79 | 20.10B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services Inc (WST) Stock Price Down 4.85% on Jan 16 - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by EULAV Asset Management - MarketBeat
Earnings Preview: What to Expect From West Pharmaceutical Services' Report - inkl
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Gov. Braun accelerates life sciences leadership with more than 1,300 new high wage jobs across the state - WBIW
Is It Time To Reassess West Pharmaceutical Services (WST) After Its Recent Share Price Slide - Yahoo Finance
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services - Med Device Online
Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? - sharewise.com
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Benzinga
AbbVie adds Arizona plant to $10bn US manufacturing push - The Pharma Letter
Chicago's AbbVie to acquire Tempe medical device manufacturing facility - The Business Journals
Key facts: AbbVie partners with RemeGen; acquires West Pharma rights - TradingView — Track All Markets
Strategy To YieldBoost West Pharmaceutical Services From 0.3% To 5.2% Using Options - Nasdaq
AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE - marketscreener.com
West Pharmaceutical Selling SmartDose 3.5mL On-Body Delivery System Manufacturing Rights To AbbVie For $112.5 Million - Pulse 2.0
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Sahm
AbbVie to acquire West Pharmaceutical’s Arizona facility for $175 million By Investing.com - Investing.com Canada
AbbVie to acquire West Pharmaceutical’s Arizona device manufacturing facility - Indian Pharma Post
AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma - marketscreener.com
West Pharmaceutical (WST) to Sell SmartDose System Rights to Abb - GuruFocus
West Pharmaceutical (WST) Sells Arizona Facility to AbbVie for E - GuruFocus
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical (WST:NYSE) - Seeking Alpha
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie - Chartmill
West Pharmaceutical Services, Inc. $WST Shares Sold by Parnassus Investments LLC - MarketBeat
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MSN
Is West Pharmaceutical Services Inc. stock dividend yield sustainablePortfolio Performance Summary & Accurate Intraday Trading Signals - Улправда
SG Americas Securities LLC Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Moves - Yahoo Finance
Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting On 2026 Outlook And Valuation - Yahoo Finance
Will West Pharmaceutical Services Inc. stock attract ESG investorsJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - ulpravda.ru
Pharmaceutical company planning to employ 300 workers in Greenfield - Inside INdiana Business
Is West Pharmaceutical Services Inc. stock trading at attractive multiplesJuly 2025 Spike Watch & Smart Investment Allocation Insights - ulpravda.ru
Why West Pharmaceutical Services Inc. stock is a value investor pickWeekly Profit Recap & Scalable Portfolio Growth Ideas - ulpravda.ru
Will West Pharmaceutical Services Inc. stock benefit from infrastructure spendingDollar Strength & Risk Managed Investment Entry Signals - Улправда
West Pharmaceutical Services, Inc. $WST Shares Purchased by Birch Hill Investment Advisors LLC - MarketBeat
KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST - Finviz
A Look At West Pharmaceutical Services (WST) Valuation As Margins Weaken And Growth Trails Healthcare Peers - Sahm
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Analysts Offer Insights on Healthcare Companies: Agilent (A) and Tenet Healthcare (THC) - The Globe and Mail
14 Best Dividend Growth Stocks to Buy and Hold in 2026 - Insider Monkey
2026 world cup star players tips: Is West Pharmaceutical Services Inc. stock dividend yield sustainable2026 world cup usa national team round of 32 playmakers low block defense group prediction guide - ulpravda.ru
Asset Management One Co. Ltd. Buys 10,009 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc Stock Price Live, Charts & News - The Economic Times
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 25% Upside Potential - DirectorsTalk Interviews
Who Owns West Pharmaceutical Services? Top Shareholders and Recent Insider Trades - TIKR.com
Investing in West Pharmaceutical Services (NYSE:WST) three years ago would have delivered you a 20% gain - simplywall.st
West Pharmaceutical Services, Inc. $WST Shares Acquired by North Growth Management Ltd. - MarketBeat
Biotech’s New Edge: 5 Companies Mastering "How" We Dose - The Globe and Mail
Ethic Inc. Purchases 4,206 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Cwm LLC Purchases 14,789 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):